• Opium, Urine
  • Acid Alpha-Glucosidase (GAA)
  • Inherited Insulin Resistance Syndromes (INSR) Genetic Testing
  • Apolipoprotein E (Apo E) Genotyping
  • Candida albicans, Antigen
  • Cystatin C, Serum
  • Human Papilloma Virus (HPV) High Risk, Nucleic Acid Testing
  • Coagulation Factor VIII Activity Assay, Plasma
  • Carcinoembryonic Antigen (CEA), Pleural Fluid
  • SMAD4 Germline Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Pain Management Pharmacogenetics (PGx) Gene Variation Panel
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Pain Management Pharmacogenetics (PGx) Gene Variation Panel
Medical Test

ICD10
Access to Pain Management Pharmacogenetics (PGx) Gene Variation Panel is restricted.